LB Pharmaceuticals (LBRX) announced the appointment of James Rawls, Pharm.D., as Senior Vice President, SVP, of Regulatory Affairs. Rawls joins LB Pharmaceuticals from Boston Biodevelopment, where he served as Executive Vice President and Chief Regulatory Officer
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LBRX:
- Opening Day: Cerebras Systems withdraws IPO filing
- Buy Rating for LB Pharmaceuticals Driven by Promising LB-102 and Market Potential
- LB Pharmaceuticals to present posters on Phase 2 NOVA trial of LB-102
- LB Pharmaceuticals initiated with an Outperform at Leerink
- LB Pharmaceuticals initiated with a Buy at Stifel